IRIS Accounts Production v22.1.0.628 07313450 Board of Directors Board of Directors 1.12.20 30.11.21 30.11.21 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure073134502020-11-30073134502021-11-30073134502020-12-012021-11-30073134502019-11-30073134502019-12-012020-11-30073134502020-11-3007313450ns16:EnglandWales2020-12-012021-11-3007313450ns15:PoundSterling2020-12-012021-11-3007313450ns11:Director12020-12-012021-11-3007313450ns11:Director22020-12-012021-11-3007313450ns11:PrivateLimitedCompanyLtd2020-12-012021-11-3007313450ns11:SmallEntities2020-12-012021-11-3007313450ns11:AuditExempt-NoAccountantsReport2020-12-012021-11-3007313450ns11:SmallCompaniesRegimeForDirectorsReport2020-12-012021-11-3007313450ns11:SmallCompaniesRegimeForAccounts2020-12-012021-11-3007313450ns11:FullAccounts2020-12-012021-11-3007313450ns11:RegisteredOffice2020-12-012021-11-3007313450ns6:CurrentFinancialInstruments2021-11-3007313450ns6:CurrentFinancialInstruments2020-11-3007313450ns6:Non-currentFinancialInstruments2021-11-3007313450ns6:Non-currentFinancialInstruments2020-11-3007313450ns6:ShareCapital2021-11-3007313450ns6:ShareCapital2020-11-3007313450ns6:RetainedEarningsAccumulatedLosses2021-11-3007313450ns6:RetainedEarningsAccumulatedLosses2020-11-3007313450ns6:ShortLeaseholdAssetsns6:LandBuildings2020-12-012021-11-3007313450ns6:PlantMachinery2020-12-012021-11-3007313450ns6:FurnitureFittings2020-12-012021-11-3007313450ns6:MotorVehicles2020-12-012021-11-3007313450ns6:ComputerEquipment2020-12-012021-11-3007313450ns6:ShortLeaseholdAssetsns6:LandBuildings2020-11-3007313450ns6:PlantMachinery2020-11-3007313450ns6:FurnitureFittings2020-11-3007313450ns6:ShortLeaseholdAssetsns6:LandBuildings2021-11-3007313450ns6:PlantMachinery2021-11-3007313450ns6:FurnitureFittings2021-11-3007313450ns6:ShortLeaseholdAssetsns6:LandBuildings2020-11-3007313450ns6:PlantMachinery2020-11-3007313450ns6:FurnitureFittings2020-11-3007313450ns6:MotorVehicles2020-11-3007313450ns6:ComputerEquipment2020-11-3007313450ns6:MotorVehicles2021-11-3007313450ns6:ComputerEquipment2021-11-3007313450ns6:MotorVehicles2020-11-3007313450ns6:ComputerEquipment2020-11-3007313450ns6:AdditionsToInvestments2021-11-3007313450ns6:CostValuation2021-11-3007313450ns6:WithinOneYearns6:CurrentFinancialInstruments2021-11-3007313450ns6:WithinOneYearns6:CurrentFinancialInstruments2020-11-30
REGISTERED NUMBER: 07313450 (England and Wales)

















Pharmora Limited

Financial Statements

for the Year Ended 30 November 2021






Pharmora Limited (Registered number: 07313450)

Contents of the Financial Statements
for the year ended 30 November 2021










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Pharmora Limited

Company Information
for the year ended 30 November 2021







DIRECTORS: Dr S J Pinches
I R Pinches





REGISTERED OFFICE: 24 Cornwall Road
Dorchester
Dorset
DT1 1RX





REGISTERED NUMBER: 07313450 (England and Wales)





ACCOUNTANTS: Read Woodruff
Chartered Accountants
24 Cornwall Road
Dorchester
Dorset
DT1 1RX

Pharmora Limited (Registered number: 07313450)

Statement of Financial Position
30 November 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 486,152 448,751
Investments 5 84 -
486,236 448,751

CURRENT ASSETS
Debtors 6 406,421 870,911
Cash at bank and in hand 827,228 572,203
1,233,649 1,443,114
CREDITORS
Amounts falling due within one year 7 632,060 705,485
NET CURRENT ASSETS 601,589 737,629
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,087,825

1,186,380

CREDITORS
Amounts falling due after more than one
year

8

-

(308,804

)

PROVISIONS FOR LIABILITIES (20,691 ) (9,579 )
NET ASSETS 1,067,134 867,997

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 1,067,132 867,995
SHAREHOLDERS' FUNDS 1,067,134 867,997

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 August 2022 and were signed on its behalf by:



Dr S J Pinches - Director



I R Pinches - Director


Pharmora Limited (Registered number: 07313450)

Notes to the Financial Statements
for the year ended 30 November 2021


1. STATUTORY INFORMATION

Pharmora Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Leasehold property - Straight line over 20 years
Plant and machinery - 20% on cost
Office equipment - 10% on cost
Motor vehicles - 20% on cost
Computer equipment - 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2020 - 7 ) .

Pharmora Limited (Registered number: 07313450)

Notes to the Financial Statements - continued
for the year ended 30 November 2021


4. PROPERTY, PLANT AND EQUIPMENT
Leasehold Plant and Office
property machinery equipment
£    £    £   
COST
At 1 December 2020 515,914 18,570 1,441
Additions 3,093 - -
At 30 November 2021 519,007 18,570 1,441
DEPRECIATION
At 1 December 2020 79,196 12,850 496
Charge for year 25,796 3,714 144
At 30 November 2021 104,992 16,564 640
NET BOOK VALUE
At 30 November 2021 414,015 2,006 801
At 30 November 2020 436,718 5,720 945

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 December 2020 - 10,578 546,503
Additions 71,881 7,235 82,209
At 30 November 2021 71,881 17,813 628,712
DEPRECIATION
At 1 December 2020 - 5,210 97,752
Charge for year 11,980 3,174 44,808
At 30 November 2021 11,980 8,384 142,560
NET BOOK VALUE
At 30 November 2021 59,901 9,429 486,152
At 30 November 2020 - 5,368 448,751

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
Additions 84
At 30 November 2021 84
NET BOOK VALUE
At 30 November 2021 84

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade debtors 76,569 533,496
Amounts recoverable on contracts 131,505 234,305
Other debtors 198,347 103,110
406,421 870,911

Pharmora Limited (Registered number: 07313450)

Notes to the Financial Statements - continued
for the year ended 30 November 2021


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade creditors 179,855 105,275
Taxation and social security 121,988 369,185
Other creditors 330,217 231,025
632,060 705,485

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2021 2020
£    £   
Other creditors - 308,804

9. OTHER FINANCIAL COMMITMENTS

The company has future operating lease commitments totalling £659.

10. ULTIMATE CONTROLLING PARTY

The controlling party is Medicorum Limited.